Buprenorphine Treatment: Advanced Practice Nurses Add Capacity.

Joanne Spetz, Laurie Hailer,Caryl Gay,Matthew Tierney,Laura A Schmidt,Bethany Phoenix,Susan A Chapman

Health affairs (Project Hope)（2022）

引用 6|浏览4

暂无评分

摘要

During the COVID-19 pandemic, there was slower growth in the number of new waivers authorizing clinicians to provide buprenorphine treatment for opioid use disorder. However, treatment capacity grew at a stable rate as a result of already authorized clinicians obtaining waivers for larger patient panels. Advanced practice nurses accounted for the largest portion of capacity growth during the pandemic.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要